Georgetown University Hospital has closed a genetics analysis laboratory that performs testing for breast cancer patients after two women were falsely told they do not have an aggressive form of breast cancer known as HER2-positive, the Washington Post reports. CMS officials are investigating allegations by an employee of the lab that hospital administrators did not respond to a request to notify patients of a failed quality-control inspection and recommend that they undergo retesting...
